{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Omnicell, Inc. technically bullish or bearish?
As of October 31, 2025, Omnicell, Inc. exhibits a neutral technical trend with mixed indicators, showing mild bullishness on weekly and monthly MACD but short-term bearishness in daily moving averages, while significantly underperforming the S&P 500 with year-to-date and one-year returns of -22.51% and -29.11%, respectively.
Is Omnicell, Inc. technically bullish or bearish?
As of October 31, 2025, Omnicell, Inc. shows a neutral technical trend with mixed indicators, including a mildly bullish MACD on weekly and monthly charts, but has underperformed the S&P 500 with a year-to-date return of -25.04% compared to the index's 16.30%.
Omnicell, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics
Omnicell, Inc., a small-cap company in the Computers - Software & Consulting sector, has recently adjusted its valuation metrics, showing a high P/E ratio and a low PEG ratio. Despite outperforming the S&P 500 over the past week, the company has faced significant declines over the past year and five years.
Is Omnicell, Inc. technically bullish or bearish?
As of October 31, 2025, Omnicell, Inc. shows a neutral technical trend with mixed signals, including mildly bullish MACD indicators, but has significantly underperformed the S&P 500 with year-to-date and one-year returns of -24.60% and -30.98%, respectively.
Is Omnicell, Inc. technically bullish or bearish?
As of October 31, 2025, Omnicell, Inc. shows a neutral technical trend with mixed indicators, underperforming the S&P 500 significantly with year-to-date and one-year returns of -24.60% and -30.98%, respectively.
Omnicell Stock Soars 13.56%, Hits Intraday High of $34.30
Omnicell, Inc. saw a notable increase in its stock price on October 30, 2025, reaching an intraday high of USD 34.30. The company has reported positive net profit growth over the last three quarters, despite facing longer-term challenges. It maintains a low debt-to-equity ratio and strong institutional support.
Omnicell, Inc. Experiences Revision in Stock Evaluation Amid Competitive Market Landscape
Omnicell, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 78 and a low PEG ratio of 0.21, suggesting potential growth. Compared to peers, its performance metrics reveal a complex landscape, with a notable decline over the past year against the S&P 500's return.
Omnicell, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Landscape
Omnicell, Inc. has recently adjusted its valuation metrics, reporting a P/E ratio of 78 and a low PEG ratio of 0.21, suggesting a favorable growth outlook. Compared to peers, its performance indicators reveal a challenging year-to-date return of -32.84%, contrasting with the S&P 500's positive return.
Is Omnicell, Inc. technically bullish or bearish?
As of September 2, 2025, Omnicell, Inc. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 significantly year-to-date and over the past year.
Is Omnicell, Inc. overvalued or undervalued?
As of August 15, 2025, Omnicell, Inc. is considered very attractive due to its undervaluation indicated by a PEG ratio of 0.21 and a P/E ratio of 78, despite struggling with significant declines in returns compared to the S&P 500.
Omnicell's Valuation Upgrade Signals Improved Financial Stability and Investor Confidence
Omnicell, Inc. has recently experienced a valuation grade adjustment, reflecting a significant change in its financial standing. Key metrics indicate a compelling valuation landscape, with strong institutional support and improved profitability, despite some recent negative performance. The company maintains a low debt-to-equity ratio, enhancing its financial stability.
Is Omnicell, Inc. overvalued or undervalued?
As of May 23, 2025, Omnicell, Inc. is considered overvalued with a high P/E ratio of 78, a premium EV to EBIT ratio of 135.19, and underperformance against the S&P 500, leading to a valuation grade downgrade from very attractive to fair.
Is Omnicell, Inc. technically bullish or bearish?
As of June 2, 2025, Omnicell, Inc. shows a mildly bearish trend, with mixed signals from indicators like MACD and KST being mildly bullish, while daily moving averages and Bollinger Bands indicate bearish tendencies.
Who are in the management team of Omnicell, Inc.?
As of March 2022, the management team of Omnicell, Inc. includes Randall Lipps as Chairman, President, and CEO, with James Judson as Lead Independent Director and other board members including Robin Seim, Joanne Bauer, Vance Moore, and Mark Parrish.
What does Omnicell, Inc. do?
Omnicell, Inc. offers automation and analytics software for medication and supply management in the healthcare sector. As of March 2025, it reported net sales of $270 million and a net loss of $7 million, with a market cap of approximately $1.62 billion.
How big is Omnicell, Inc.?
As of Jun 18, Omnicell, Inc. has a market capitalization of $1.62 billion, with recent net sales of $1.14 billion and a net profit of $21.18 million over the last four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
